These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 27130732)
1. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition. Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L Elife; 2016 Apr; 5():. PubMed ID: 27130732 [TBL] [Abstract][Full Text] [Related]
2. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan. Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679 [TBL] [Abstract][Full Text] [Related]
3. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan. Gerin I; Ury B; Breloy I; Bouchet-Seraphin C; Bolsée J; Halbout M; Graff J; Vertommen D; Muccioli GG; Seta N; Cuisset JM; Dabaj I; Quijano-Roy S; Grahn A; Van Schaftingen E; Bommer GT Nat Commun; 2016 May; 7():11534. PubMed ID: 27194101 [TBL] [Abstract][Full Text] [Related]
4. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Yoshida-Moriguchi T; Campbell KP Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296 [TBL] [Abstract][Full Text] [Related]
5. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation. Riemersma M; Froese DS; van Tol W; Engelke UF; Kopec J; van Scherpenzeel M; Ashikov A; Krojer T; von Delft F; Tessari M; Buczkowska A; Swiezewska E; Jae LT; Brummelkamp TR; Manya H; Endo T; van Bokhoven H; Yue WW; Lefeber DJ Chem Biol; 2015 Dec; 22(12):1643-52. PubMed ID: 26687144 [TBL] [Abstract][Full Text] [Related]
6. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan. Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355 [TBL] [Abstract][Full Text] [Related]
7. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512 [TBL] [Abstract][Full Text] [Related]
8. Cell endogenous activities of fukutin and FKRP coexist with the ribitol xylosyltransferase, TMEM5. Nishihara R; Kobayashi K; Imae R; Tsumoto H; Manya H; Mizuno M; Kanagawa M; Endo T; Toda T Biochem Biophys Res Commun; 2018 Mar; 497(4):1025-1030. PubMed ID: 29477842 [TBL] [Abstract][Full Text] [Related]
9. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan. Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527 [TBL] [Abstract][Full Text] [Related]
10. Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-l-Ribitol Pyrophosphorylase A Muscular Dystrophy. van Tol W; van Scherpenzeel M; Alsady M; Riemersma M; Hermans E; Kragt E; Tasca G; Kamsteeg EJ; Pennings M; van Beusekom E; Vermeulen JR; van Bokhoven H; Voermans NC; Willemsen MA; Ashikov A; Lefeber DJ Clin Chem; 2019 Oct; 65(10):1295-1306. PubMed ID: 31375477 [TBL] [Abstract][Full Text] [Related]
11. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan. Manya H; Endo T Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406 [TBL] [Abstract][Full Text] [Related]
12. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals. Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954 [TBL] [Abstract][Full Text] [Related]
13. CDP-glycerol inhibits the synthesis of the functional Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773 [TBL] [Abstract][Full Text] [Related]
14. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes. Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC Elife; 2021 Jan; 10():. PubMed ID: 33513091 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review. Taniguchi-Ikeda M; Morioka I; Iijima K; Toda T Mol Aspects Med; 2016 Oct; 51():115-24. PubMed ID: 27421908 [TBL] [Abstract][Full Text] [Related]
16. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy. Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP Elife; 2023 Feb; 12():. PubMed ID: 36723429 [TBL] [Abstract][Full Text] [Related]